Optimel Manuka Dry Eye Drops Solution/ Drops
FDA Label NDC 73024-399

Full FDA labeling including Indications, Dosage, Usage, and Precautions

Structured Product Label

The following Structured Product Label (SPL) was submitted to the FDA by Melcare Biomedical Pty Ltd for the product Optimel Manuka Dry Eye Drops (NDC 73024-399). This document serves as the official prescribing information, containing essential scientific data and clinical materials required for healthcare providers and patients.

This specific version of the label includes detailed information regarding other, active ingredients, purpose, uses, warnings, do not use, when using this product, stop use and ask a doctor if, and other regulatory disclosures. Use the navigation below to review specific sections of the FDA submission.

Label Section Quick Index

→ Other

→ Active Ingredients

→ Purpose

→ Uses

→ Warnings

→ Do Not Use

→ When Using This Product

→ Stop Use And Ask A Doctor If

→ Keep Out Of Reach Of Children.

→ Directions

→ Other Information

→ Inactive Ingredients

→ Questions?

→ Principal Display Panel

Other

Drug Facts

Active Ingredients

Glycerin 0.2%

Purpose

Lubricant

Uses

for the temporary relief of burning and irritation due to dryness of the eye.
for use as a protectant against further irritation or to relieve dryness of the eye.

Warnings

For external use only

Do Not Use

if you have a history of hypersensitivity or sensitive to honey or benzoate preservatives without seeking medical advice.
if solution changes color or becomes cloudy.
if packaging is damaged.
serious conditions should be managed under the supervision of a doctor.

When Using This Product

Before first use: check tamper ring is attached to cap base – remove cap and discard ring.
to avoid contamination, do not touch tip of container to any surface.
replace cap after using.
remove contact lenses before using.
wait at least 10 minutes before contact lens insertion.
Initial stinging and redness on drop application is to be expected.